Usefulness of molnupiravir and the combination with sotrovimab for COVID-19 patients in a tertiary hospital of Japan

被引：0
|
作者：
Seki, Masafumi [1 ]
Karaushi, Haruka [1 ]
Mitsutake, Kotaro [1 ]
机构：
[1] Saitama Med Univ Int Med Ctr, Dept Infect Dis & Infect Control, Saitama, Japan
来源：
RESPIROLOGY | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AP05-116
引用
收藏
页码：209 / 210
页数：2
相关论文
共 50 条
  • [1] Combination Treatment of Molnupiravir With Sotrovimab for COVID-19 Patients in Japan
    Seki, M.
    Karaushi, H.
    Mitsutake, K.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [2] Paxlovid, molnupiravir and sotrovimab safe for COVID-19 infections
    [J]. Reactions Weekly, 2024, 2021 (1) : 10 - 10
  • [3] Evaluation of the Detection of Pathogens in Hospitalized Patients with COVID-19 at a Tertiary Hospital in Japan
    Suzuki, Michiyo
    Hayakawa, Kayoko
    Asai, Yusuke
    Matsunaga, Nobuaki
    Terada, Mari
    Ohtsu, Hiroshi
    Toyoda, Ako
    Takasaki, Jin
    Hojo, Masayuki
    Yanagawa, Yasuaki
    Saito, Sho
    Yamamoto, Kei
    Ide, Satoshi
    Akiyama, Yutaro
    Suzuki, Tetsuya
    Moriya, Ataru
    Mezaki, Kazuhisa
    Ohmagari, Norio
    [J]. JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2022, 75 (04) : 419 - 422
  • [4] Molnupiravir for Covid-19 in Nonhospitalized Patients
    Roberfroid, Dominique
    Jespers, Vicky
    Hulstaert, Frank
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (13):
  • [5] Fluoxetine and Molnupiravir: A Synergistic Combination for COVID-19 Treatment?
    Pashaei, Yaser
    [J]. HOSPITAL PHARMACY, 2022, 57 (05) : 603 - 604
  • [6] Efficacy and safety of molnupiravir for COVID-19 patients
    Fatima, Maurish
    Azeem, Saleha
    Saeed, Junaid
    Shahid, Abia
    Cheema, Huzaifa Ahmad
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 102 : 118 - 121
  • [7] Comparison of effectiveness and safety of molnupiravir versus sotrovimab for COVID-19: A systematic review and meta-analysis
    Amani, Bahman
    Amani, Behnam
    [J]. IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (04)
  • [8] Sotrovimab-Flashes of Safety in COVID-19 Patients
    Braik, F. A.
    Hasan, M. Y.
    [J]. DRUG SAFETY, 2022, 45 (10) : 1189 - 1190
  • [9] Efficacy of Sotrovimab (SOT), Molnupiravir (MOL), and Nirmatrelvir/Ritponavir (N/R) and Tolerability of Molnupiravir in Outpatients at High Risk for Severe COVID-19
    Kauer, Victoria
    Totschnig, David
    Waldenberger, Ferdinand
    Augustin, Max
    Karolyi, Mario
    Naegeli, Michelle
    Wenisch, Christoph
    Zoufaly, Alexander
    [J]. VIRUSES-BASEL, 2023, 15 (05):
  • [10] Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform
    Zheng, Bang
    Green, Amelia C. A.
    Tazare, John
    Curtis, Helen J.
    Fisher, Louis
    Nab, Linda
    Schultze, Anna
    Mahalingasivam, Viyaasan
    Parker, Edward P. K.
    Hulme, William J.
    Bacon, Sebastian C. J.
    DeVito, Nicholas J.
    Bates, Christopher
    Evans, David
    Inglesby, Peter
    Drysdale, Henry
    Davy, Simon
    Cockburn, Jonathan
    Morton, Caroline E.
    Hickman, George
    Ward, Tom
    Smith, Rebecca M.
    Parry, John
    Hester, Frank
    Harper, Sam
    Mehrkar, Amir
    Eggo, Rosalind M.
    Walker, Alex J.
    Evans, Stephen J. W.
    Douglas, Ian J.
    MacKenna, Brian
    Goldacre, Ben
    Tomlinson, Laurie A.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2022, 379
12345